Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, today announced that it shipped four additional LuViva® Advanced Cervical Scan systems to Bangladesh for use in the country’s...
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, today announced that it has sold the first LuViva® Advanced Cervical Scan to its distributor in Russia. “Russia is an important...
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, today announced that it has shipped five LuViva® Advanced Cervical Scans to Nairobi County Health Services Sector for use in the...
Guided Therapeutics, Inc. (OTCQB: GTHP) announced today that it has received an order and payment for a third LuViva® Advanced Cervical Scan and 500 single-use disposable cervical guides for Bulgaria. “We are very excited about this growing market in Eastern Europe...
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it has reached a licensing agreement with Shenghuo Medical, LLC, for exclusive sales and manufacturing rights...
